Trials / Unknown
UnknownNCT04012879
Study Evaluating the Efficacy and Safety With CD19CAR-T for Relapsed or Refractory Acute Lymphoblastic Leukemia
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Chinese PLA General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is a single-arm, open label, phase I clinical trial to evaluate the safety and feasibility of CD19CAR-T in treatment of relapsed / refractory acute lymphoblasic leukemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | CD19 CART | CD19 CART |
Timeline
- Start date
- 2019-05-01
- Primary completion
- 2021-04-30
- Completion
- 2021-06-30
- First posted
- 2019-07-09
- Last updated
- 2019-07-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04012879. Inclusion in this directory is not an endorsement.